PT  - JOURNAL ARTICLE
AU  - Menda, Kunal
AU  - Laird, Lucas
AU  - Kochenderfer, Mykel J.
AU  - Caceres, Rajmonda S.
TI  - Explaining COVID-19 Outbreaks with Reactive SEIRD Models
AID  - 10.1101/2021.02.09.21251440
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.09.21251440
4099  - http://medrxiv.org/content/early/2021/02/12/2021.02.09.21251440.short
4100  - http://medrxiv.org/content/early/2021/02/12/2021.02.09.21251440.full
AB  - COVID-19 epidemics have varied dramatically in nature across the United States, where some counties have clear peaks in infections, and others have had a multitude of unpredictable and non-distinct peaks. In this work, we seek to explain the diversity in epidemic progressions by considering an extension to the compartmental SEIRD model. The model we propose uses a neural network to predict the infection rate as a function of time and of the prevalence of the disease. We provide a methodology for fitting this model to available county-level data describing aggregate cases and deaths. Our method uses Expectation-Maximization in order to overcome the challenge of partial observability—that the system’s state is only partially reflected in available data. We fit a single model to data from multiple counties in the United States exhibiting different behavior. By simulating the model, we show that it is capable of exhibiting both single peak and multi-peak behavior, reproducing behavior observed in counties both in and out of the training set. We also numerically compare the error of simulations from our model with a standard SEIRD model, showing that the proposed extensions are necessary to be able to explain the spread of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis study analyzes publicly available data on the spread of COVID-19 and did not require clinical trials.Funding StatementThis material is supported by the Under Secretary of Defense for Research and Engineering under Air Force Contract No. FA8702-15-D-0001. Any opinions, findings, conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the Under Secretary of Defense for Research and Engineering.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study analyzes only publicly available COVID-19 data and did not require any approvals.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated and/or analyzed during the current study are available in the COVID-19 Data Repository by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (https://github.com/CSSEGISandData/COVID-19) https://github.com/CSSEGISandData/COVID-19 https://github.com/sisl/rseird AbbreviationsCE-EMCertainty-Equivalent Expectation-Maximization. 2R-SEIRDReactive-SEIRD. 1SEIRDSusceptible, Exposed, Infected, Recovered, Deceased. 1